Journal articles
Spigelman A; Lu M, 2019, 'Adherence to referral guidelines: Genetic testing in an Australian triple negative breast cancer (TNBC) cohort', International Journal of Health Governance,, 24, pp. 6 - 18, http://dx.doi.org/10.1108/IJHG-09-2018-0045
Joo JE; Dowty JG; Milne RL; Wong EM; Dugué PA; English D; Hopper JL; Goldgar DE; Giles GG; Southey MC; Sexton A; Christian A; Trainer A; Spigelman A; Fellows A; Shelling A; De Fazio A; Blackburn A; Crook A; Meiser B; Patterson B; Clarke C; Saunders C; Hunt C; Scott C; Amor D; Marsh D; Edkins E; Salisbury E; Haan E; Neidermayr E; Macrae F; Farshid G; Lindeman G; Chenevix-Trench G; Mann G; Gill G; Thorne H; Campbell I; Hickie I; Winship I; Goldblatt J; Flanagan J; Kollias J; Visvader J; Stone J; Taylor J; Burke J; Saunus J; Forbes J; Beesley J; Kirk J; French J; Tucker K; Wu K; Phillips K; Lipton L; Andrews L; Lobb E; Walker L; Kentwell M; Spurdle A; Cummings M; Gleeson M; Harris M; Jenkins M; Young MA; Delatycki M; Wallis M; Burgess M; Price M; Brown M; Bogwitz M; Field M; Friedlander M; Gattas M; Saleh M; Hayward N; Pachter N; Cohen P; Duijf P; James P; Simpson P; Fong P; Butow P; Williams R; Kefford R; Scott R; Balleine R; Dawson SJ; Lok S; O'Connell S; Greening S; Nightingale S; Edwards S; Fox S; McLachlan SA; Lakhani S; Thomas S; Antill Y, 2018, 'Heritable DNA methylation marks associated with susceptibility to breast cancer /631/67/69 /631/337/176/1988 /692/699/67/1347 /692/308/2056 /45 /45/61 article', Nature Communications, 9, http://dx.doi.org/10.1038/s41467-018-03058-6
Kable AK; Spigelman AD, 2018, 'Why clinicians involved with adverse events need much better support', International Journal of Health Governance, 23, pp. 312 - 315, http://dx.doi.org/10.1108/IJHG-09-2018-0049
Rankin NM; Lai M; Miller D; Beale P; Spigelman A; Prest G; Turley K; Simes J, 2018, 'Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change', Asia-Pacific Journal of Clinical Oncology, 14, pp. 74 - 83, http://dx.doi.org/10.1111/ajco.12765
Mikropoulos C; Selkirk CGH; Saya S; Bancroft E; Vertosick E; Dadaev T; Brendler C; Page E; Dias A; Evans DG; Rothwell J; Maehle L; Axcrona K; Richardson K; Eccles D; Jensen T; Osther PJ; Van Asperen CJ; Vasen H; Kiemeney LA; Ringelberg J; Cybulski C; Wokolorczyk D; Hart R; Glover W; Lam J; Taylor L; Salinas M; Feliubadaló L; Oldenburg R; Cremers R; Verhaegh G; Van Zelst-Stams WA; Oosterwijk JC; Cook J; Rosario DJ; Buys SS; Conner T; Domchek S; Powers J; Ausems MG; Teixeira MR; Maia S; Izatt L; Schmutzler R; Rhiem K; Foulkes WD; Boshari T; Davidson R; Ruijs M; Helderman-Van Den Enden AT; Andrews L; Walker L; Snape K; Henderson A; Jobson I; Lindeman GJ; Liljegren A; Harris M; Adank MA; Kirk J; Taylor A; Susman R; Chen-Shtoyerman R; Pachter N; Spigelman A; Side L; Zgajnar J; Mora J; Brewer C; Gadea N; Brady AF; Gallagher D; Van Os T; Donaldson A; Stefansdottir V; Barwell J; James PA; Murphy D; Friedman E; Nicolai N; Greenhalgh L; Obeid E; Murthy V; Copakova L; McGrath J; Teo SH; Strom S; Kast K; Leongamornlert DA; Chamberlain A; Pope J; Newlin AC; Aaronson N; Ardern-Jones A; Bangma C; Castro E; Dearnaley D; Eyfjord J; Falconer A, 2018, 'Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition', British Journal of Cancer, 118, pp. 266 - 276, http://dx.doi.org/10.1038/bjc.2017.429
Balachandran VP; Łuksza M; Zhao JN; Makarov V; Moral JA; Remark R; Herbst B; Askan G; Bhanot U; Senbabaoglu Y; Wells DK; Cary CIO; Grbovic-Huezo O; Attiyeh M; Medina B; Zhang J; Loo J; Saglimbeni J; Abu-Akeel M; Zappasodi R; Riaz N; Smoragiewicz M; Larkin Kelley Z; Basturk O; Gönen M; Levine AJ; Allen PJ; Fearon DT; Merad M; Gnjatic S; Iacobuzio-Donahue CA; Wolchok JD; Dematteo RP; Chan TA; Greenbaum BD; Merghoub T; Leach SD; Johns AL; Scott Mead R; Gill AJ; Chang DK; McKay SH; Chantrill LA; Chin VT; Chou A; Humphris JL; Pajic M; Steinmann A; Arshi M; Drury A; Froio D; Morgan A; Timpson P; Hermann D; Vennin C; Warren S; Pinese M; Wu J; Pinho AV; Tucker K; Andrews L; Samra JS; Arena J; Pavlakis N; High HA; Mittal A; Biankin AV; Bailey P; Martin S; Musgrove EA; Jones MD; Nourse C; Jamieson NB; Stoita A; Williams D; Spigelman A; Waddell N; Pearson JV; Patch AM; Nones K; Newell F; Mukhopadhyay P; Addala V; Kazakoff S; Holmes O; Leonard C; Wood S; Xu C; Grimmond SM; Hofmann O; Wilson PJ; Christ A; Bruxner T; Asghari R; Merrett ND; Pavey D; Das A; Goodwin A; Cosman PH; Ismail K, 2017, 'Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer', Nature, 551, pp. S12 - S16, http://dx.doi.org/10.1038/nature24462
Fazekas-Lavu M; Parker A; Spigelman AD; Scott RJ; Epstein RJ; Jensen M; Samaras K, 2017, 'Thyroid cancer in a patient with lynch syndrome – case report and literature review', Therapeutics and Clinical Risk Management, 13, pp. 915 - 918, http://dx.doi.org/10.2147/TCRM.S121812
Rankin N; Lai M; Miller D; Beale P; Spigelman AD; Prest G; Turley K; Simes J, 2017, 'Evidence into practice in cancer multidisciplinary teams. Results from a multi-institutional quantitative survey and implications for policy change.', Asia-Pacific Journal of Clinical Oncology, 110, pp. 1937 - 1944, http://dx.doi.org/10.1111/ajco.1275
Spigelman AD; Rendalls S; McLaws ML; Gray A, 2016, 'Antimicrobial stewardship: Australia', International Journal of Health Governance, 21, pp. 139 - 149, http://dx.doi.org/10.1108/IJHG-02-2016-0010
Talseth-Palmer BA; Bauer DC; Sjursen W; Evans TJ; Mcphillips M; Proietto A; Otton G; Spigelman AD; Scott RJ, 2016, 'Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families', Cancer Medicine, 5, pp. 929 - 941, http://dx.doi.org/10.1002/cam4.628
Wong-Brown M; McPhillips M; Gleeson M; Spigelman AD; Meldrum CJ; Dooley S; Scott RJ, 2016, 'When is a mutation not a mutation: The case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans', Hereditary Cancer in Clinical Practice, 14, http://dx.doi.org/10.1186/s13053-015-0045-y
Pokrywczynska M; Adamowicz J; Czapiewska M; Balcerczyk D; Jundzill A; Nowacki M; Petros P; Drewa T, 2016, 'Targeted therapy for stress urinary incontinence: A systematic review based on clinical trials', Expert Opinion on Biological Therapy, 16, pp. 233 - 242, http://dx.doi.org/10.1517/14712598.2016.1118459
Spigelman AD; Rendalls S, 2015, 'Clinical governance in Australia', Clinical Governance, 20, pp. 56 - 73, http://dx.doi.org/10.1108/CGIJ-03-2015-0008
Humphris JL; Johns AL; Simpson SH; Cowley MJ; Pajic M; Chang DK; Nagrial AM; Chin VT; Chantrill LA; Pinese M; Mead RS; Gill AJ; Samra JS; Kench JG; Musgrove EA; Tucker KM; Spigelman AD; Waddell N; Grimmond SM; Biankin AV, 2014, 'Clinical and pathologic features of familial pancreatic cancer', Cancer, 120, pp. 3669 - 3675, http://dx.doi.org/10.1002/cncr.28863
Purrington KS; Slettedahl S; Bolla MK; Michailidou K; Czene K; Nevanlinna H; Bojesen SE; Andrulis IL; Cox A; Hall P; Carpenter J; Yannoukakos D; A. Haiman C; Fasching PA; Mannermaa A; Winqvist R; Brenner H; Lindblom A; Chenevix-Trench G; Benitez J; Swerdlow A; Kristensen V; Guénel P; Meindl A; Darabi H; Eriksson M; Fagerholm R; Aittomaki K; Blomqvist C; Nordestgaard BG; Nielsen SF; Flyger H; Wang X; Olswold C; Olson JE; Mulligan AM; Knight JA; Tchatchou S; Reed MWR; Cross SS; Liu J; Li J; Humphreys K; Clarke C; Scott R; Balleine R; Baxter R; Braye S; Dahlstrom J; Forbes J; Lee S; Marsh D; Morey A; Pathmanathan N; Spigelman A; Wilcken N; Yip D; Landrith S; Oeser S; Rübner M; Williams E; Ryder-Mills E; Sargus K; Colleran G; Rowan A; Jones A; Andersen DU; Arnadottir MB; Bank A; Kjeldgård D; Pita H; Alonso C; Herrero D; Álvarez N; Zamora MP; Menendez P; Lacey J; Wang S; Ma H; Lu Y; Clague J; Deapen D; Pinder R; Lee E; Schumacher F; Horn-Ross P; Reynolds P; Nelson D; Ziegler H; Wolf S; Hermann V; Hellebrand H; Engert S; Fostira F; Fountzilas G; Konstantopoulou I; Henderson BE; Le Marchand L; Ekici AB; Hartmann A, 2014, 'Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade', Human Molecular Genetics, 23, pp. 6034 - 6046, http://dx.doi.org/10.1093/hmg/ddu300
Butel-Simoes GI; Spigelman AD, 2014, 'Analysis of patient reports on the referral process to two NSW cancer genetic services', Familial Cancer, 13, pp. 333 - 343, http://dx.doi.org/10.1007/s10689-014-9710-y
Mattick JS; Dziadek MA; Terrill BN; Kaplan W; Spigelman AD; Bowling FG; Dinger ME, 2014, 'The impact of genomics on the future of medicine and health', Medical Journal of Australia, 201, pp. 17 - 20, http://dx.doi.org/10.5694/mja13.10920
Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJW; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HFA, 2014, 'Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome', Familial Cancer, 13, pp. 57 - 63, http://dx.doi.org/10.1007/s10689-013-9674-3
Teng I; Spigelman A, 2014, 'Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing', Familial Cancer, 13, pp. 311 - 324, http://dx.doi.org/10.1007/s10689-013-9695-y
Bancroft EK; Page EC; Castro E; Lilja H; Vickers A; Sjoberg D; Assel M; Foster CS; Mitchell G; Drew K; Mæhle L; Axcrona K; Evans DG; Bulman B; Eccles D; McBride D; Van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Cybulski C; Wokolorczyk D; Selkirk C; Hulick PJ; Bojesen A; Skytte AB; Lam J; Taylor L; Oldenburg R; Cremers R; Verhaegh G; Van Zelst-Stams WA; Oosterwijk JC; Blanco I; Salinas M; Cook J; Rosario DJ; Buys S; Conner T; Ausems MG; Ong KR; Hoffman J; Domchek S; Powers J; Teixeira MR; Maia S; Foulkes WD; Taherian N; Ruijs M; Den Enden ATHV; Izatt L; Davidson R; Adank MA; Walker L; Schmutzler R; Tucker K; Kirk J; Hodgson S; Harris M; Douglas F; Lindeman GJ; Zgajnar J; Tischkowitz M; Clowes VE; Susman R; Ramón Y Cajal T; Patcher N; Gadea N; Spigelman A; Van Os T; Liljegren A; Side L; Brewer C; Brady AF; Donaldson A; Stefansdottir V; Friedman E; Chen-Shtoyerman R; Amor DJ; Copakova L; Barwell J; Giri VN; Murthy V; Nicolai N; Teo SH; Greenhalgh L; Strom S; Henderson A; McGrath J; Gallagher D; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Costello P; Eyfjord J; Rothwell J; Falconer A; Gronberg H; Hamdy FC, 2014, 'Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study', European Urology, 66, pp. 489 - 499, http://dx.doi.org/10.1016/j.eururo.2014.01.003
Talseth-Palmer BA; Wijnen JT; Andreassen EK; Barker D; Jagmohan-Changur S; Tops CM; Meldrum C; Spigelman A; Hes FJ; Van Wezel T; Vasen HFA; Scott RJ, 2013, 'The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients', Hereditary Cancer in Clinical Practice, 11, http://dx.doi.org/10.1186/1897-4287-11-20
Pascoe SW; Veitch C; Crossland LJ; Beilby JJ; Spigelman A; Stubbs J; Harris MF, 2013, 'Patients' experiences of referral for colorectal cancer', BMC Family Practice, 14, http://dx.doi.org/10.1186/1471-2296-14-124
Talseth-Palmer BA; Holliday EG; Evans TJ; McEvoy M; Attia J; Grice DM; Masson AL; Meldrum C; Spigelman A; Scott RJ, 2013, 'Continuing difficulties in interpreting CNV data: Lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients', BMC Medical Genomics, 6, http://dx.doi.org/10.1186/1755-8794-6-10
Maringe C; Walters S; Rachet BP; Butler J; Fields T; Finan PJ; Maxwell R; Nedrebo BS; Pahlman LA; Sjovall A; Spigelman AD; Engholm G; Sjovall A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris EJA; Mcgahan CE; Tracey E; Turner DJ; Richards MA; Coleman MP, 2013, 'Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000-2007', ACTA Oncologica, 52, pp. 919 - 932, http://dx.doi.org/10.3109/0284186X.2013.764008
Goldsbury D; Harris MF; Pascoe S; Barton MB; Olver I; Spigelman AD; Beilby J; Veitch C; Weller D; O Connell DL, 2013, 'The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study', BMJ Open, 3, pp. 1 - 13, http://dx.doi.org/10.1136/bmjopen-2012-002325
Harris MF; Pascoe S; Crossland L; Beilby J; Veitch C; Spigelman A; Weller D, 2012, 'Patients with colorectal cancer A qualitative study of referral pathways and continuing care', Australian Family Physician, 41, pp. 899 - 902
Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Colas C; Möller P; Hes FJ; Hodgson SV; Olderode-Berends MJW; Aretz S; Heinimann K; Gomez Garcia EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HFA, 2012, 'Is colorectal surveillance indicated in patients with PTEN mutations?', Colorectal Disease, 14, http://dx.doi.org/10.1111/j.1463-1318.2012.03121.x
Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ, 2012, 'DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome', Cancer Epidemiology, 36, pp. 183 - 189, http://dx.doi.org/10.1016/j.canep.2011.09.003
Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Ashton KA; Tops CM; Evans T-J; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HFA; Scott RJ, 2012, 'Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts', Hereditary Cancer in Clinical Practice, 10, pp. A32 - A32, http://dx.doi.org/10.1186/1897-4287-10-s2-a32
Reeves S; Meldrum C; Groombridge C; Spigelman AD; Suchy J; Kurzawski G; Lubinski J; Scott RJ, 2012, 'DNA repair gene polymorphisms and risk of early onset colorectal cancer: findings from a qualitative study in general practice', Cancer Epidemiology, 36, pp. 183 - 189
Spigelman AD; Debono DS; Oates K; Dunn A; Braithwaite J, 2012, 'Patient safety teaching in Australian medical schools: a national survey', Clinical Risk, 18, pp. 46 - 51, http://cr.rsmjournals.com/content/18/2/46.full.pdf+html
Harris MF; Pascoe S; Crossland LJ; Beilby J; Veitch C; Spigelman AD; Weller D, 2012, 'Referral pathways and continuing care for patients with colorectal cancer: findings from a qualitative study in general practice', AUSTRALIAN FAMILY PHYSICIAN, 41, pp. 899 - 902
Goldsbury D; Harris MF; Pascoe S; Olver I; Barton M; Spigelman AD; O''connell D, 2012, 'Socio-demographic and other patient characteristics associated with time between colonoscopy and surgery, and choice of treatment centre for colorectal cancer: a retrospective cohort study', BMJ Open, 2, pp. e001070, http://dx.doi.org/10.1136/bmjopen-2012-001070
Zilliacus EM; Meiser B; Lobb EA; Kelly P; Barlow-Stewart K; Kirk J; Spigelman AD; Warwick L; Tucker K, 2011, 'Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast/ovarian cancer genetic counseling?', Genetics in Medicine, 13, pp. 933 - 941
Vilain R; Dudding T; Braye S; Groombridge C; Meldrum C; Spigelman AD; Ackland S; Ashman L; Scott R, 2011, 'Can a familial gastrointestinal tumour syndrome be allelic with Waardenberg Syndrome?', Clinical Genetics: an international journal of genetics and molecular medicine, 79, pp. 1 - 7, http://dx.doi.org/10.1111/j.1399-0004.2010.01489.x
Spigelman AD, 2011, 'Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007: the international cancer benchmarking partnership', Lancet, 377, pp. 127 - 138, http://dx.doi.org/10.1016/S0140
Travaglia JF; Debono DS; Spigelman AD; Braithwaite J, 2011, 'Clinical governance: a review of key concepts in the literature', Clinical Governance: an International Journal, 16, pp. 62 - 77, http://dx.doi.org/10.1108/14777271111104592
Talseth-Palmer B; Brenne I; Ashton K; Evans T; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman AD; Lubinski J; Scott R, 2011, 'Colorectal cancer susceptibility Ioci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome', Journal of Medical Genetics, 48, pp. 279 - 284, http://dx.doi.org/10.1136/jmg.2010.079962
Spigelman AD, 2011, 'Long term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial', Lancet, 378, pp. 2081 - 2087, http://dx.doi.org/10.1016/S0140
Spigelman AD, 2011, 'New Governments: New policies', Clinical Governance: an International Journal, 16, pp. 250 - 251, http://dx.doi.org/10.1108/14777271111170607
Harris MF; Pascoe S; Crossland LJ; Beilby J; Veitch C; Spigelman AD, 2011, 'Referral pathways in colorectal cancer: findings from a qualitative study in general practice', Medical Journal of Australia, 195, pp. 178 - 179
Mitra AV; Bancroft EK; Barbachano Y; Page EC; Foster C; Jameson CF; Mitchell G; Lindeman GJ; Stapleton AM; Suthers G; Evans D; Cruger DG; Blanco I; Mercer CL; Kirk J; Maehle LO; Hodgson S; Walker L; Izatt L; Douglas F; Tucker K; Dorkins H; Clowes VE; Male AM; Donaldson A; Brewer C; Doherty R; Bulman B; Osther PJS; Salinas M; Eccles DM; Axcrona K; Jobson I; Newcombe B; Cybulski C; Rubinstein WS; Buys S; Townshend S; Friedman E; Domchek SM; Ramon y cajal T; Spigelman AD; Teo SH; Nicolai N; Aaronson NK; Ardern-jones AT; Bangma CH; Dearnaley DP; Eyfjord JE; Falconer AD; Gronberg ; Hamdy FC; Johannsson OT; Khoo VS; Kote-jarai Z; Lilja H; Lubinski J; Melia J; Moynihan C; Peock S; Rennert G; Schroder F; Sibley PEC; Suri M; Wilson P; Bignon YJ; Strom S; Tischkowitz MD; Liljegren A; Ilencikova D; Abeles A; Kyriacou K; Van asperen CJ; Kiemeney LALM; Easton D; Eeles RA, 2011, 'Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: Preliminary analysis of the results of the IMPACT study', British Journal of Urology International, 107, pp. 28 - 39, http://dx.doi.org/10.1111/j.1464-410X.2010.09648.x
Spigelman AD, 2010, 'Australian Perspectives: Health System Reform', Clinical Governance: an International Journal, 15, pp. 46 - 49
Talseth-Palmer B; McPhillips M; Groombridge C; Spigelman AD; Scott R, 2010, 'MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer', Hereditary Cancer in Clinical Practice, 8, pp. 1 - 10, http://dx.doi.org/10.1186/1897-4287-8-5
Frydoonfar H; McGrath D; Hunt JA; Dunkley C; Spigelman AD, 2010, 'Serum Glutathione transferase does not respond to Indole-3-carbinol: a pilot study', Therapeutics and Clinical Risk Management, 2010, pp. 225 - 231
Kable A; Gibberd R; Spigelman AD, 2009, 'Adverse events in five surgical procedures', Clinical Governance: an International Journal, 14, pp. 145 - 155
Spigelman AD, 2009, 'Clinical outcome information: the patient patient', Clinical Governance: an International Journal, 14, pp. 245 - 247
Latchford A; Neale K; Spigelman AD; Phillips R; Clark S, 2009, 'Features of Duodenal Cancer in Patients With Familial Adenomatous Polyposis', Clinical Gastroenterology and Hepatology, 7, pp. 659 - 663
Johnstone D; Talseth-Palmer B; Evans T; Spigelman AD; Groombridge C; Milward EA; Olynyk JK; Suchy J; Kurzawski G; Lubinski J; Scott R, 2009, 'Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age', International Journal of Cancer, 125, pp. 78 - 83
Mireskandari S; Angster J; Meiser B; Thewes B; Groombridge C; Spigelman AD; Andrews L, 2009, 'Impact of familial adenomatous polyposis (FAP) on young adults: A qualitative study', Journal of Genetic Counseling, 18, pp. 409 - 417
Back to profile page
https://orcid.org/0000-0002-7409-1684